Materia Medica Holding: Infections trials

The registry lists 10 Infections studies with Materia Medica Holding as lead sponsor. 0 are open to participants now and 10 have results posted.

Phase 3 5Phase 4 4No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Clinical Study of Efficacy and Safety of Raphamin in the Treatment of ARVI in Children 12-18 Years OldCompletedNCT04918771Phase 3Results posted
• Study on Safety and Effectiveness of Ergoferon in the Treatment of Flu / ARVI in Outpatients.CompletedNCT04413929Results posted
• Clinical Trial of Efficacy and Safety of ММН-407 in Acute Respiratory Viral InfectionCompletedNCT04244084Phase 3Results posted
• Clinical Trial of Efficacy and Safety of Anaferon in the Treatment of Acute Respiratory Viral InfectionsCompletedNCT03707912Phase 4Results posted
• Clinical Trial of Efficacy and Safety of Anaferon for Children Liquid Dosage Form in the Treatment of Acute Upper Respiratory InfectionsCompletedNCT03162458Phase 3Results posted
• Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Viral Intestinal Infections in ChildrenCompletedNCT03039699Phase 4Results posted
• Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in ChildrenCompletedNCT03039621Phase 4Results posted
• Efficacy of Anaferon for Children in the Treatment of Influenza and Acute Respiratory Viral Infections in ChildrenCompletedNCT02072174Phase 4Results posted
• Clinical Trial of Safety and Clinical Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in ChildrenCompletedNCT01843842Phase 3Results posted
• Clinical Trial of Safety and Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in AdultsCompletedNCT01765920Phase 3Results posted